We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+14.21%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$987M
AUM Growth
+$120M
Cap. Flow
+$63.5M
Cap. Flow %
6.44%
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$6.71M
2
DXCM icon
DexCom
DXCM
+$6.59M
3
X
US Steel
X
+$6.1M
4
CMBT
CMB.TECH NV
CMBT
+$5.09M
5
SPLK
Splunk Inc
SPLK
+$4.85M

Top Sells

Rank Stock Value
1
GOOS
Canada Goose Holdings
GOOS
+$21.9M
2
STZ icon
Constellation Brands
STZ
+$9.52M
3
LUMN icon
Lumen
LUMN
+$7.13M
4
WY icon
Weyerhaeuser
WY
+$6.3M
5
FDX icon
FedEx
FDX
+$6.07M

Sector Composition

Rank Sector Weight
1 Healthcare 16.75%
2 Technology 15.19%
3 Consumer Discretionary 13.45%
4 Industrials 12.06%
5 Financials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
1
Biogen
BIIB
$29.9B
$6.22M 0.63%
26,305
+21,325
+428% +$6.71M
CRM icon
2
Salesforce
CRM
$134B
$5.88M 0.6%
37,156
+30,204
+434% +$4.68M
X
3
DELISTED
US Steel
X
$5.58M 0.57%
+286,565
New +$6.1M
DXCM icon
4
DexCom
DXCM
$27.6B
$5.58M 0.57%
+187,420
New +$6.59M
CMBT
5
CMB.TECH NV
CMBT
$4.57B
$5.29M 0.54%
+649,304
New +$5.09M
ELV icon
6
Elevance Health
ELV
$81.9B
$5.03M 0.51%
17,532
+16,646
+1,879% +$4.81M
HCC icon
7
Warrior Met Coal
HCC
$4.23B
$5.01M 0.51%
164,921
+2,992
+2% +$81.9K
SPLK
8
DELISTED
Splunk Inc
SPLK
$4.84M 0.49%
+38,870
New +$4.85M
HLF icon
9
Herbalife
HLF
$1.23B
$4.26M 0.43%
80,478
+45,442
+130% +$2.61M
TTWO icon
10
Take-Two Interactive
TTWO
$43B
$3.79M 0.38%
40,112
+35,446
+760% +$3.44M
GHDX
11
DELISTED
Genomic Health, Inc.
GHDX
$3.77M 0.38%
53,865
+5,565
+12% +$413K
NXPI icon
12
NXP Semiconductors
NXPI
$68B
$3.73M 0.38%
42,140
+38,947
+1,220% +$3.42M
ABMD
13
DELISTED
Abiomed Inc
ABMD
$3.69M 0.37%
+12,921
New +$4.29M
CI icon
14
Cigna
CI
$76.6B
$3.64M 0.37%
22,655
+19,054
+529% +$3.48M
W icon
15
Wayfair
W
$11.1B
$3.52M 0.36%
+23,739
New +$3.1M
PDD icon
16
Pinduoduo
PDD
$118B
$3.33M 0.34%
+134,281
New +$3.6M
RCL icon
17
Royal Caribbean
RCL
$78.7B
$3.33M 0.34%
29,044
+15,235
+110% +$1.73M
ON icon
18
ON Semiconductor
ON
$33.8B
$3.27M 0.33%
159,097
+142,656
+868% +$2.94M
CCL icon
19
Carnival Corporation Ltd
CCL
$36.1B
$3.25M 0.33%
64,128
+33,817
+112% +$1.87M
GLNG icon
20
Golar LNG
GLNG
$4.95B
$3.25M 0.33%
154,217
+28,937
+23% +$638K
VST icon
21
Vistra
VST
$55.1B
$3.2M 0.32%
122,953
+104,093
+552% +$2.63M
BABA icon
22
Alibaba
BABA
$269B
$3.19M 0.32%
17,469
+15,523
+798% +$2.61M
CTXS
23
DELISTED
Citrix Systems Inc
CTXS
$3.18M 0.32%
31,900
+20,825
+188% +$2.16M
FCX icon
24
Freeport-McMoran
FCX
$90B
$3.14M 0.32%
243,404
+230,083
+1,727% +$2.78M
LMNX
25
DELISTED
Luminex Corp
LMNX
$3.1M 0.31%
134,636
+40,836
+44% +$1.03M

Similar funds

GSA Capital Partners's Q1 2019 Portfolio in Review

As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.

  • GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
  • GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
  • GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
  • GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
  • GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
  • GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.

Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.